Seth Landefeld is Chair, Department of Medicine and the Spencer Chair in Medical Science Leadership.
Dr. Landefeld brings to UAB an infectious enthusiasm for all the wonderful opportunities in academic medicine – to care for people, to teach, to discover, and to build a healthy society. Recognizing the UAB Department of Medicine as a well established national leader, he envisions the Department as the go-to department in the United States for faculty, learners, and staff who have the ambition, ability, and drive to work together with their colleagues at UAB to make it the most exciting academic medical center in the country.
Prior to joining UAB in September 2012, Dr. Landefeld founded and led the development of UCSF’s Division of Geriatrics, and he ultimately served as Associate Chair of the Department of Medicine for Strategic Planning and Implementation. With over 30 faculty, the Division has established a record of innovation in research, education, and patient care and has emerged as a national leader in the development of outstanding faculty. The Division’s outstanding faculty and innovative programs have attracted increasing support from the philanthropic community, with annual gifts of $1 million and an endowment of over $5 million. At UCSF, Landefeld also directed the Hartford Foundation Center of Excellence in Academic Geriatrics, founded Program for the Aging Century, and led the editorial team that produces JAMA’s series, “Care of the Aging Patient.”
Dr. Landefeld’s work has aimed to transform and personalize health care to meet the needs of older Americans and their families in this Aging Century, a century that will be dominated by the medical and social issues of the aging global population. His research has improved outcomes of older persons with serious illness. In landmark studies of acutely ill hospitalized elders, Landefeld and his colleagues invented the Acute Care for Elders (ACE) Unit, a novel method for improving patients’ functional outcomes. This model has been adapted at medical centers nationwide. In incremental studies of anticoagulant therapy, he developed the first valid, reliable measure of hemorrhagic complications, designed and validated risk assessment indices for anticoagulant-related bleeding, developed interventions to prevent major bleeding, and demonstrated their efficacy in clinical trials.
Dr. Landefeld completed his undergraduate work at Harvard and New College, Oxford, where he was a Rhodes Scholar. He received his M.D. from Yale. He trained in internal medicine at UCSF and in clinical epidemiology at Harvard Medical School. He is a member of the American Society for Clinical Investigation and the Association of American Physicians and was recently a Fellow at the Center for Advanced Study in the Behavioral Sciences at Stanford University. He is Past-President of the Society of General Internal Medicine and served on the Boards of the American Geriatrics Society, the Association of Directors of Geriatric Academic Programs, and San Francisco’s Institute on Aging. In 2011, Dr. Landefeld received the Robert J. Glaser Award “For Exceptional Contributions to Education and Research”, the highest award of the Society of General Internal Medicine.